Deqing Hu

4.2k total citations
27 papers, 2.1k citations indexed

About

Deqing Hu is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Deqing Hu has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Virology. Recurrent topics in Deqing Hu's work include Epigenetics and DNA Methylation (12 papers), Genomics and Chromatin Dynamics (10 papers) and Cancer-related gene regulation (7 papers). Deqing Hu is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Genomics and Chromatin Dynamics (10 papers) and Cancer-related gene regulation (7 papers). Deqing Hu collaborates with scholars based in United States, China and Spain. Deqing Hu's co-authors include Ali Shilatifard, Hans-Martin Herz, Xin Gao, Edwin R. Smith, Marc A. Morgan, Zusen Fan, Bao-Xue Ge, Chenhui Li, Boquan Jin and Hongyu Zhang and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Deqing Hu

26 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deqing Hu United States 22 1.6k 392 326 195 162 27 2.1k
Alicia N. Schep United States 10 1.6k 1.0× 335 0.9× 233 0.7× 362 1.9× 146 0.9× 12 1.9k
Carlos‐Filipe Pereira Portugal 24 1.9k 1.2× 296 0.8× 253 0.8× 276 1.4× 252 1.6× 54 2.4k
Emer Bourke Ireland 18 907 0.6× 503 1.3× 342 1.0× 227 1.2× 157 1.0× 23 1.6k
Srividya Swaminathan United States 17 1.1k 0.6× 323 0.8× 364 1.1× 149 0.8× 361 2.2× 42 1.6k
Jonathan W. Snow United States 19 1.1k 0.7× 465 1.2× 358 1.1× 336 1.7× 308 1.9× 42 2.0k
Diego E. Montoya–Durango United States 14 810 0.5× 626 1.6× 261 0.8× 272 1.4× 131 0.8× 22 1.5k
Yijie Gao China 15 2.4k 1.5× 314 0.8× 715 2.2× 401 2.1× 229 1.4× 31 2.8k
Alistair M. Chalk Australia 23 1.8k 1.1× 461 1.2× 163 0.5× 360 1.8× 92 0.6× 46 2.1k
Elizabeth A. Chavez Canada 24 1.9k 1.1× 300 0.8× 412 1.3× 219 1.1× 335 2.1× 41 2.9k
Gustavo Gutierrez-Cruz United States 15 1.6k 1.0× 590 1.5× 236 0.7× 341 1.7× 217 1.3× 17 2.3k

Countries citing papers authored by Deqing Hu

Since Specialization
Citations

This map shows the geographic impact of Deqing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deqing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deqing Hu more than expected).

Fields of papers citing papers by Deqing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deqing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deqing Hu. The network helps show where Deqing Hu may publish in the future.

Co-authorship network of co-authors of Deqing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Deqing Hu. A scholar is included among the top collaborators of Deqing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deqing Hu. Deqing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoqiang, Shan Huang, Hui Bai, et al.. (2025). The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts. Science Translational Medicine. 17(793). eado4370–eado4370.
2.
Chen, Xiaoqing, Kai Wu, Xiaolu Zhao, et al.. (2024). DOT1L/H3K79me2 represses HIV-1 reactivation via recruiting DCAF1. Cell Reports. 43(7). 114368–114368. 2 indexed citations
3.
Bai, Hui, Ting Deng, R. Xiao, et al.. (2023). PRMT2 promotes HIV-1 latency by preventing nucleolar exit and phase separation of Tat into the Super Elongation Complex. Nature Communications. 14(1). 7274–7274. 4 indexed citations
4.
Huang, Shan, Lei Yang, Zhenyu Hu, et al.. (2022). Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity. Nature Communications. 13(1). 6578–6578. 36 indexed citations
5.
Zhang, Weiyu, Ruiqin Zheng, Xiaoyun Li, et al.. (2021). Single-Cell Analysis of the Pan-Cancer Immune Microenvironment and scTIME Portal. Cancer Immunology Research. 9(8). 939–951. 47 indexed citations
6.
Gao, Ru, Shuqi Huang, Jun Cheng, et al.. (2020). Competition between PAF1 and MLL1/COMPASS confers the opposing function of LEDGF/p75 in HIV latency and proviral reactivation. Science Advances. 6(20). eaaz8411–eaaz8411. 20 indexed citations
7.
Wang, Wei, Chi‐Kuo Hu, An Zeng, et al.. (2020). Changes in regeneration-responsive enhancers shape regenerative capacities in vertebrates. Science. 369(6508). 133 indexed citations
8.
Martín, Glòria Mas, Enrique Blanco, Cecilia Ballaré, et al.. (2018). Promoter bivalency favors an open chromatin architecture in embryonic stem cells. Nature Genetics. 50(10). 1452–1462. 93 indexed citations
9.
Hu, Deqing, Xin Gao, Kaixiang Cao, et al.. (2017). Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification. Molecular Cell. 65(3). 460–475.e6. 74 indexed citations
10.
Rickels, Ryan, Deqing Hu, Clayton K. Collings, et al.. (2016). An Evolutionary Conserved Epigenetic Mark of Polycomb Response Elements Implemented by Trx/MLL/COMPASS. Molecular Cell. 63(2). 318–328. 57 indexed citations
11.
Li, Chong, Zhao Yang, Ying Du, et al.. (2014). BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer In Vivo. Clinical Cancer Research. 20(15). 4001–4013. 36 indexed citations
12.
Gardini, Alessandro, David Baillat, Matteo Cesaroni, et al.. (2014). Integrator Regulates Transcriptional Initiation and Pause Release following Activation. Molecular Cell. 56(1). 128–139. 136 indexed citations
13.
Herz, Hans-Martin, Deqing Hu, & Ali Shilatifard. (2014). Enhancer Malfunction in Cancer. Molecular Cell. 53(6). 859–866. 128 indexed citations
14.
Hu, Deqing, Edwin R. Smith, Alexander S. Garruss, et al.. (2013). The Little Elongation Complex Functions at Initiation and Elongation Phases of snRNA Gene Transcription. Molecular Cell. 51(4). 493–505. 53 indexed citations
15.
Hu, Deqing, Alexander S. Garruss, Xin Gao, et al.. (2013). The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells. Nature Structural & Molecular Biology. 20(9). 1093–1097. 142 indexed citations
16.
Lee, Jung‐Shin, Alexander S. Garrett, Kuangyu Yen, et al.. (2012). Codependency of H2B monoubiquitination and nucleosome reassembly on Chd1. Genes & Development. 26(9). 914–919. 58 indexed citations
17.
Zhang, Hongyu, Deqing Hu, Chenhui Li, et al.. (2012). Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death and Differentiation. 20(3). 456–464. 261 indexed citations
18.
Smith, Edwin R., Chengqi Lin, Alexander S. Garrett, et al.. (2011). The Little Elongation Complex Regulates Small Nuclear RNA Transcription. Molecular Cell. 44(6). 954–965. 71 indexed citations
19.
Hu, Deqing, Shengwu Liu, Lei Shi, et al.. (2010). Cleavage of Survivin by Granzyme M Triggers Degradation of the Survivin-X-linked Inhibitor of Apoptosis Protein (XIAP) Complex to Free Caspase Activity Leading to Cytolysis of Target Tumor Cells. Journal of Biological Chemistry. 285(24). 18326–18335. 39 indexed citations
20.
Zhang, Tong, Deqing Hu, Chang‐Hui Ge, et al.. (2010). PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells. Molecular Cancer. 9(1). 72–72. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicia N. Schep Breakdown of academic impact, for papers by Carlos‐Filipe Pereira Breakdown of academic impact, for papers by Emer Bourke Breakdown of academic impact, for papers by Srividya Swaminathan Breakdown of academic impact, for papers by Jonathan W. Snow Breakdown of academic impact, for papers by Diego E. Montoya–Durango Breakdown of academic impact, for papers by Yijie Gao Breakdown of academic impact, for papers by Alistair M. Chalk Breakdown of academic impact, for papers by Elizabeth A. Chavez Breakdown of academic impact, for papers by Gustavo Gutierrez-Cruz
Rankless by CCL
2026